fortune for ox in 2024
Intech Investment Management LLC Sells 3,075 Shares of Sun Communities, Inc. (NYSE:SUI)Charles Schwab Investment Management Inc. increased its position in shares of Organon & Co. ( NYSE:OGN – Free Report ) by 35.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,323,051 shares of the company’s stock after buying an additional 875,128 shares during the period. Charles Schwab Investment Management Inc. owned 1.29% of Organon & Co. worth $63,570,000 as of its most recent filing with the SEC. Several other hedge funds and other institutional investors also recently added to or reduced their stakes in OGN. Versant Capital Management Inc grew its stake in Organon & Co. by 200.2% in the 2nd quarter. Versant Capital Management Inc now owns 1,207 shares of the company’s stock valued at $25,000 after acquiring an additional 805 shares during the period. Prospera Private Wealth LLC acquired a new stake in shares of Organon & Co. in the third quarter valued at about $25,000. William B. Walkup & Associates Inc. purchased a new stake in shares of Organon & Co. during the second quarter worth about $31,000. Abich Financial Wealth Management LLC raised its position in shares of Organon & Co. by 5,646.3% during the 3rd quarter. Abich Financial Wealth Management LLC now owns 2,356 shares of the company’s stock worth $45,000 after purchasing an additional 2,315 shares during the last quarter. Finally, Atlas Capital Advisors LLC raised its position in shares of Organon & Co. by 2,236.5% during the 2nd quarter. Atlas Capital Advisors LLC now owns 2,243 shares of the company’s stock worth $46,000 after purchasing an additional 2,147 shares during the last quarter. Institutional investors and hedge funds own 77.43% of the company’s stock. Wall Street Analysts Forecast Growth Several equities research analysts have commented on the company. JPMorgan Chase & Co. lowered Organon & Co. from a “neutral” rating to an “underweight” rating and boosted their price objective for the stock from $18.00 to $20.00 in a research note on Friday, September 6th. Evercore ISI upgraded Organon & Co. to a “strong-buy” rating in a research report on Wednesday, September 18th. Organon & Co. Stock Down 0.7 % OGN stock opened at $15.87 on Friday. The company has a market cap of $4.09 billion, a price-to-earnings ratio of 3.15, a PEG ratio of 0.75 and a beta of 0.84. The firm has a 50-day moving average of $17.26 and a two-hundred day moving average of $19.65. Organon & Co. has a 12 month low of $10.84 and a 12 month high of $23.10. The company has a current ratio of 1.70, a quick ratio of 1.21 and a debt-to-equity ratio of 17.73. Organon & Co. ( NYSE:OGN – Get Free Report ) last released its quarterly earnings data on Thursday, October 31st. The company reported $0.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.90 by ($0.03). The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. Organon & Co. had a return on equity of 644.70% and a net margin of 20.30%. Organon & Co.’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.78 earnings per share. As a group, analysts forecast that Organon & Co. will post 3.89 earnings per share for the current fiscal year. Organon & Co. Dividend Announcement The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Tuesday, November 12th will be issued a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a yield of 7.06%. The ex-dividend date is Tuesday, November 12th. Organon & Co.’s dividend payout ratio is presently 22.22%. About Organon & Co. ( Free Report ) Organon & Co develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. See Also Five stocks we like better than Organon & Co. What is Short Interest? How to Use It The Latest 13F Filings Are In: See Where Big Money Is Flowing What is the NASDAQ Stock Exchange? 3 Penny Stocks Ready to Break Out in 2025 How to Use High Beta Stocks to Maximize Your Investing Profits FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Receive News & Ratings for Organon & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organon & Co. and related companies with MarketBeat.com's FREE daily email newsletter .
Azimuth AI: Edge Computing Silicon Company Closes $11.5 Million In FundingHackertron: Revolutionizing Digital Optimization With Patented AI TechnologyIntech Investment Management LLC Makes New Investment in Cross Country Healthcare, Inc. (NASDAQ:CCRN)
Potential suitors have again begun circling ITV, Britain’s biggest terrestrial commercial broadcaster, after a prolonged period of share price weakness and renewed questions about its long-term strategic destiny. Sky News has learnt that a number of possible bidders for parts or all of the company, whose biggest shows include Love Island, have in recent weeks held early-stage discussions about teaming up to pursue a potential transaction. TV industry sources said this weekend that CVC Capital Partners and a major European broadcaster - thought to be France's Groupe TF1 - were among those which had been starting to study the merits of a potential offer. The sources added that RedBird Capital-owned All3Media and Mediawan, which is backed by the private equity giant KKR, were also on the list of potential suitors for the ITV Studios production arm. One cautioned this weekend that none of the work on potential bids was at a sufficiently advanced stage to require disclosure under the UK's stock market disclosure rules, and suggested that ITV's board - chaired by Andrew Cosslett - had not received any recent unsolicited approaches. That meant that the prospects of any formal approach materialising was highly uncertain. The person added, however, that Dame Carolyn McCall, ITV's long-serving chief executive, had been discussing with the company's financial advisers the merits of a demerger or other form of separation of its two main business units. More from Money Ann Summers' family owners to explore options for lingerie chain Thousands of jobs to go at Bosch in latest blow to German car industry Money blog: How much does it cost to freeze your eggs and can it go wrong? Three women who've done it share their stories Its main banking advisers are Goldman Sachs, Morgan Stanley and Robey Warshaw. ITV's shares are languishing at just 65.5p, giving the whole company a market capitalisation of £2.51bn. The stock rose more than 5% on Friday amid vague market chatter about a possible takeover bid. Bankers and analysts believe that ITV Studios, which made Disney+'s hit show, Rivals, would be worth more than the entire company's market capitalisation in a break-up of ITV. People close to the situation said that under one possible plan being studied, CVC could be interested in acquiring ITV Studios, with a European broadcast partner taking over its broadcasting arm, including the ITVX streaming platform. "At the right price, it would make sense if CVC wanted the undervalued production business, with TF1 wanting an English language streaming service in ITVX, along with the cashflows of the declining channels," one broadcasting industry veteran said this weekend. "They would only get the assets, though, in a deal worth double the current share price." Takeover speculation about ITV, which competes with Sky News' parent company, has been a recurring theme since the company was created from the merger of Carlton and Granada more than 20 years ago. ITV said this month that it would seek additional cost savings of £20m this year as it continued to deal with the fallout from last year's strikes by Hollywood writers and actors. It added that revenues at the Studios arm would decline over the current financial year, with advertising revenues sharply lower in the fourth quarter than in the same period a year earlier because of the tough comparison with 2023's Rugby World Cup. Allies of Dame Carolyn, who has run ITV since 2018, argue that she has transformed ITV, diversifying further into production and overhauling its digital capabilities. The majority of ITV's revenue now comes from profitable and growing areas, including ITVX and the Studios arm, they said. By 2026, those areas are expected to account for more than two-thirds of the group's sales. This year, its production arm was responsible for the most-viewed drama of the year on any channel or platform, Mr Bates versus The Post Office. In its third-quarter update earlier this month, Dame Carolyn said the company's "good strategic progress has continued in the first nine months of 2024 driven by strong execution and industry-leading creativity". "ITV Studios is performing well despite the expected impact of both the writer's strike and a softer market from free-to-air broadcasters." She said the unit would achieve record profits this year. ITV and CVC declined to comment, while TF1, RedBird and Mediawan did not respond to requests for comment.
Preview: Hearts vs. Hibernian - prediction, team news, lineups
Vancouver Canucks (12-7-3, in the Pacific Division) vs. Detroit Red Wings (10-11-2, in the Atlantic Division) Detroit; Sunday, 12:30 p.m. EST BOTTOM LINE: The Vancouver Canucks visit the Detroit Red Wings after the Canucks took down the Buffalo Sabres 4-3 in overtime. Detroit has gone 5-6-1 at home and 10-11-2 overall. The Red Wings have gone 3-3-2 in games they serve more penalty minutes than their opponents. Vancouver has a 12-7-3 record overall and a 9-2-0 record on the road. The Canucks have a +two scoring differential, with 71 total goals scored and 69 given up. Sunday's game is the first time these teams square off this season. TOP PERFORMERS: Dylan Larkin has 12 goals and six assists for the Red Wings. Lucas Raymond has six goals and four assists over the past 10 games. Quinn Hughes has five goals and 20 assists for the Canucks. Elias Pettersson has scored five goals with eight assists over the last 10 games. LAST 10 GAMES: Red Wings: 4-5-1, averaging 2.5 goals, 4.3 assists, 2.9 penalties and 6.3 penalty minutes while giving up 2.9 goals per game. Canucks: 5-5-0, averaging 3.2 goals, 5.7 assists, 3.7 penalties and 9.1 penalty minutes while giving up 3.2 goals per game. INJURIES: Red Wings: None listed. Canucks: None listed. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .
Drones, planes or UFOs? Americans abuzz over mysterious New Jersey sightings
All mobile owners at risk of huge FINE that could ruin 2025 over ‘utterly ridiculous’ rule
U.S. President-elect Donald Trump and the head of NATO have met for talks on global security, the military alliance said Saturday. In a brief statement, NATO said Trump and its secretary general, Mark Rutte, met on Friday in Palm Beach, Florida. “They discussed the range of global security issues facing the Alliance,” the statement said without giving details. RELATED STORY | Trump appearance at SpaceX launch reinforces Musk's relationship with the president-elect It appeared to be Rutte's first meeting with Trump since his Nov. 5 election. Rutte had previously congratulated Trump and said “his leadership will again be key to keeping our Alliance strong" and that he looked forward to working with him. Trump has for years expressed skepticism about the Western alliance and complained about the defense spending of many of its member nations, which he regarded as too low. He depicted NATO allies as leeches on the U.S. military and openly questioned the value of the alliance that has defined American foreign policy for decades. He threatened not to defend NATO members that fail to meet defense-spending goals. Rutte and his team also met Trump's pick as national security adviser, U.S. Rep. Michael Waltz, and other members of the president-elect's national security team, the NATO statement said. RELATED STORY | New details emerge about the Department of Government Efficiency's proposed cuts Rutte took over at the helm of NATO in October.